Alterity Therapeutics (ATHE) Goodwill (2020 - 2025)

Alterity Therapeutics (ATHE) posted quarterly Goodwill of $4.0 million for Q4 2025, up 17.72% quarter-over-quarter from $3.4 million in Q2 2025.

Alterity Therapeutics (ATHE) Goodwill (2020 - 2025) Analysis & Trends

Alterity Therapeutics' Goodwill history runs 2 years deep, the most recent figure standing at $4.0 million for Q4 2025.

In Q4 2025, Goodwill changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $3.4 million, changed N/A from the prior year.
Goodwill for Q4 2025 stood at $4.0 million, up from $3.4 million in the prior quarter.
The five-year high for Goodwill was $4.0 million in Q4 2025, with the low at $3.4 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.57 Bn	131.72 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn
3	Argenx Se	65.44 Bn	60.25 Bn	1.37 Bn
4	Moderna	60.06 Bn	54.93 Bn	52.00 Mn
5	BeOne Medicines	42.16 Bn	37.06 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.89 Bn	28.58 Bn	992.69 Mn
7	BioNTech SE	28.11 Bn	9.72 Bn	668.28 Mn
8	Insmed	27.59 Bn	26.43 Bn	358.27 Mn
9	Royalty Pharma	27.33 Bn	26.49 Bn	-
10	Alterity Therapeutics	49.04 Mn	16.74 Mn	-

Download Data